ORGO Dividend: Organogenesis Holdings Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

ORGO Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	465	482	433	450	468	338
Revenue Growth (YoY)	2%	11%	-4%	-4%	38%	30%
Cost of Revenue	118	115	106	105	114	87
Gross Profit	346	366	326	345	353	251
Selling, General & Admin	299	294	269	283	250	204
Research & Development	45	50	44	39	30	20
Operating Expenses	345	344	314	323	280	224
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-6	-2	10	20	63	17
Income Tax Expense	-7	-3	5	4	-31	0
Net Income	-13	0	4	15	94	17
Net Income Growth	86%	-100%	-73%	-84%	453%	-144%
Shares Outstanding (Diluted)	130.84	131.67	132.74	132.4	133.7	111.4
Shares Change (YoY)	-2%	-1%	0%	-1%	20%	20%
EPS (Diluted)	-0.11	0	0.03	0.12	0.71	0.15
EPS Growth	95%	-119%	-69%	-83%	373%	-136%
Free Cash Flow	-51	4	6	-9	30	-12
Free Cash Flow Per Share	-0.38	0.03	0.04	-0.06	0.22	-0.1
Gross Margin	74.4%	75.93%	75.28%	76.66%	75.42%	74.26%
Operating Margin	0%	4.35%	2.77%	4.88%	15.38%	7.69%
Profit Margin	-2.79%	0%	0.92%	3.33%	20.08%	5.02%
Free Cash Flow Margin	-10.96%	0.82%	1.38%	-2%	6.41%	-3.55%
EBITDA	18	38	27	32	82	34
EBITDA Margin	3.87%	7.88%	6.23%	7.11%	17.52%	10.05%
D&A For EBITDA	18	17	15	10	10	8
EBIT	0	21	12	22	72	26
EBIT Margin	0%	4.35%	2.77%	4.88%	15.38%	7.69%
Effective Tax Rate	116.66%	150%	50%	20%	-49.2%	0%